Skip to content

Medicem: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Medicem

BE 0418.885.986
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€71,290
2024 · €144,185-€72,896
Equity
€967,760
2024 · €896,471+€71,290
Cash
€22,945
2024 · €5,528+€17,417
Balance sheet total
€1.0m
2024 · €938,541+€74,573

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets +€29,205

    up €29,205 (+8.5%), from €345,196 to €374,401

  • Receivables within one year +€27,952

    up €27,952 (+4.8%), from €587,817 to €615,769

    of which Other amounts receivable: +€52,783

  • Cash +€17,417

    up €17,417 (+315.1%), from €5,528 to €22,945

    mainly Depreciation (+€83,771) and Net result for the year (+€71,290)

Equity and liabilities
  • Profit (loss) carried forward +€71,290

    up €71,290 (+15.6%), from €456,471 to €527,760

  • Tax, wage and social debts +€20,669

    up €20,669 (+148.0%), from €13,962 to €34,631

  • Trade debts -€17,385

    down €17,385 (-68.1%), from €25,533 to €8,148

Income statement
  • Depreciation +€63,976

    up €63,976 (+323.2%), from €19,795 to €83,771

  • Taxes -€24,717

    down €24,717 (-48.8%), from €50,674 to €25,957

  • Services and other goods +€15,214

    up €15,214 (+13.3%), from €114,750 to €129,965

  • Financial income -€13,120

    down €13,120 (-48.8%), from €26,904 to €13,784

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €144,185
Depreciation -€63,976
Other operating charges +€638
Other operating items -€21,622
Financial income -€13,120
Financial charges +€466
Taxes +€24,717
Result 2025 €71,290

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€130,393
Investment -€112,976
Financing €0
Cash 2024 €5,528
Net result for the year +€71,290
Depreciation +€83,771
Receivables within one year -€27,952
Trade debts -€17,385
Tax, wage and social debts +€20,669
Investment in fixed assets (net) -€112,976
Cash 2025 €22,945
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €938,541 €1,013,114 +€74,573 +7.9%
Fixed assets 21/28 €345,196 €374,401 +€29,205 +8.5%
Intangible fixed assets 21 €345,196 €374,401 +€29,205 +8.5%
Current assets 29/58 €593,345 €638,714 +€45,368 +7.6%
Amounts receivable within one year 40/41 €587,817 €615,769 +€27,952 +4.8%
Trade receivables 40 €71,663 €46,832 -€24,832 -34.7%
Other amounts receivable 41 €516,154 €568,937 +€52,783 +10.2%
Cash at bank and in hand 54/58 €5,528 €22,945 +€17,417 +315.1%
Total equity and liabilities 10/49 €938,541 €1,013,114 +€74,573 +7.9%
Equity 10/15 €896,471 €967,760 +€71,290 +8.0%
Contributions 10/11 €400,000 €400,000 = 0.0%
Capital 10 €400,000 €400,000 = 0.0%
Issued capital 100 €400,000 €400,000 = 0.0%
Reserves 13 €40,000 €40,000 = 0.0%
Non-distributable reserves 130/1 €40,000 €40,000 = 0.0%
Legal reserve 130 €40,000 €40,000 = 0.0%
Profit (loss) carried forward 14 €456,471 €527,760 +€71,290 +15.6%
Amounts payable 17/49 €42,071 €45,354 +€3,284 +7.8%
Amounts payable within one year 42/48 €39,496 €42,779 +€3,284 +8.3%
Trade debts 44 €25,533 €8,148 -€17,385 -68.1%
Suppliers 440/4 €25,533 €8,148 -€17,385 -68.1%
Taxes, remuneration and social security 45 €13,962 €34,631 +€20,669 +148.0%
Taxes 450/3 €13,962 €34,631 +€20,669 +148.0%
Accrued charges and deferred income 492/3 €2,575 €2,575 = 0.0%
Operating income 70/76A €304,228 €297,821 -€6,407 -2.1%
Other operating income 74 €304,228 €297,821 -€6,407 -2.1%
Operating charges 60/66A €135,361 €213,913 +€78,552 +58.0%
Services and other goods 61 €114,750 €129,965 +€15,214 +13.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €19,795 €83,771 +€63,976 +323.2%
Other operating charges 640/8 €815 €177 -€638 -78.2%
Operating profit (loss) 9901 €168,867 €83,908 -€84,960 -50.3%
Financial income 75/76B €26,904 €13,784 -€13,120 -48.8%
Recurring financial income 75 €26,904 €13,784 -€13,120 -48.8%
Income from current assets 751 €26,904 €13,784 -€13,120 -48.8%
Other financial income 752/9 - €0 +€0
Financial charges 65/66B €912 €446 -€466 -51.1%
Recurring financial charges 65 €912 €446 -€466 -51.1%
Debt charges 650 €120 €52 -€69 -57.0%
Other financial charges 652/9 €792 €394 -€398 -50.2%
Profit (loss) for the period before taxes 9903 €194,860 €97,246 -€97,613 -50.1%
Income taxes 67/77 €50,674 €25,957 -€24,717 -48.8%
Taxes 670/3 €50,674 €25,957 -€24,717 -48.8%
Profit (loss) for the period 9904 €144,185 €71,290 -€72,896 -50.6%
Profit (loss) for the period to be appropriated 9905 €144,185 €71,290 -€72,896 -50.6%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.